Close
Nordic 9Nordic 9

Modus Therapeutics (public company)

Sweden modustx.com
See something wrong or missing? Let us know
Offices:Stockholm
Industry:Health services
Business model:B2B

Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.

Modus Therapeutics is listed on the Nasdaq First North Growth market

Investors: we tracked 5 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 20.02M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Modus Therapeutics

Name Criteria
Denmark Acarix
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Germany Atai Life Sciences
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Germany Avi Medical
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Beckley Psytech
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Spain Bigfinite
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Biofidelity
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Sweden BoneSupport
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany CatalYm
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
France CorWave
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Cydar Medical
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Top